632
IMPACT OF EPIDEMIOLOGIC EVOLUTION, DIET AND EARLY LIFE PROCESSED FOOD INTAKE ON MICROBIOME VARIANCE IN CROHN'S DISEASE. THE INTERNATIONAL ENIGMA STUDY.
Date
May 8, 2023
Explore related products in the following collection:
Tracks
Related Products
CROHN'S DISEASE STRICTURES RESPOND TO DRUG TREATMENT AND TREAT-TO-TARGET INTENSE COMBINATION THERAPY IS MORE EFFECTIVE THAN STANDARD ANTI-TNF THERAPY. TWO YEAR RESULTS OF THE STRIDENT RANDOMIZED CONTROLLED TRIAL.
BACKGROUND: After successful induction, a subset of patients with Crohn’s disease (CD) experience a secondary loss of response (LoR) to ustekinumab (UST) maintenance therapy. Dose intensification may assist in regaining response…
<i>ROSEBURIA INTESTINALIS </i>GENERATED BUTYRATE BOOSTS ANTI-PD-1 EFFICACY IN COLORECTAL CANCER BY ACTIVATING CYTOTOXIC CD8<sup>+</sup> T CELLS
BACKGROUND: Emerging evidence suggest that gut microbiota influence human health such as digestive functions and risk of sepsis…
VARIATIONS OF THE MUCOSA ASSOCIATED MICROBIOME IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS, ULCERATIVE COLITIS AND ASYMPTOMATIC CONTROLS ALONG THE GASTROINTESTINAL TRACT
This session will cover the pathogenic and non-pathogenic constituents of the gut microbiome that induce local and systemic inflammatory response and play an important role in disease development…
POLYSORBATE-80 EXACERBATES <i>PROTEUS MIRABILIS</i>-INDUCED INTESTINAL INFLAMMATION VIA STIMULATION OF ENZYME X SECRETION. THE ENIGMA STUDY.
The microbiome plays a central role in intestinal inflammation in IBD. It is influenced by environmental factors included diet…